Ovid Therapeutics Inc
NASDAQ:OVID
Income Statement
Earnings Waterfall
Ovid Therapeutics Inc
Revenue
|
391.7k
USD
|
Operating Expenses
|
-59.7m
USD
|
Operating Income
|
-59.3m
USD
|
Other Expenses
|
6.9m
USD
|
Net Income
|
-52.3m
USD
|
Income Statement
Ovid Therapeutics Inc
Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
7
N/A
|
13
+83%
|
221
+1 654%
|
221
N/A
|
214
-3%
|
208
-3%
|
1
-99%
|
1
N/A
|
1
N/A
|
2
+7%
|
0
-93%
|
0
+100%
|
0
+50%
|
0
+31%
|
|
Operating Income | |||||||||||||||||||||||||||||||
Operating Expenses |
(18)
|
(23)
|
(53)
|
(58)
|
(62)
|
(65)
|
(44)
|
(47)
|
(51)
|
(53)
|
(54)
|
(54)
|
(57)
|
(61)
|
(68)
|
(78)
|
(84)
|
(94)
|
(106)
|
(97)
|
(85)
|
(84)
|
(70)
|
(70)
|
(71)
|
(57)
|
(54)
|
(54)
|
(54)
|
(60)
|
|
Selling, General & Administrative |
(12)
|
(13)
|
(13)
|
(14)
|
(14)
|
(15)
|
(17)
|
(18)
|
(19)
|
(19)
|
(19)
|
(18)
|
(19)
|
(19)
|
(20)
|
(23)
|
(25)
|
(31)
|
(41)
|
(40)
|
(39)
|
(37)
|
(32)
|
(33)
|
(34)
|
(32)
|
(31)
|
(31)
|
(30)
|
(31)
|
|
Research & Development |
(7)
|
(10)
|
(40)
|
(44)
|
(47)
|
(50)
|
(27)
|
(29)
|
(32)
|
(34)
|
(35)
|
(36)
|
(39)
|
(42)
|
(47)
|
(54)
|
(59)
|
(63)
|
(65)
|
(57)
|
(46)
|
(47)
|
(39)
|
(37)
|
(37)
|
(25)
|
(23)
|
(23)
|
(24)
|
(29)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(18)
N/A
|
(23)
-24%
|
(53)
-136%
|
(58)
-9%
|
(62)
-6%
|
(65)
-6%
|
(44)
+32%
|
(47)
-7%
|
(51)
-8%
|
(53)
-4%
|
(54)
-1%
|
(54)
0%
|
(57)
-7%
|
(61)
-7%
|
(68)
-10%
|
(78)
-14%
|
(77)
+1%
|
(81)
-6%
|
116
N/A
|
124
+8%
|
129
+4%
|
124
-4%
|
(69)
N/A
|
(69)
N/A
|
(70)
-2%
|
(56)
+20%
|
(54)
+2%
|
(54)
+0%
|
(53)
+1%
|
(59)
-11%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
1
|
1
|
3
|
5
|
5
|
7
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(18)
N/A
|
(22)
-23%
|
(53)
-137%
|
(58)
-9%
|
(61)
-6%
|
(65)
-6%
|
(44)
+32%
|
(47)
-6%
|
(50)
-8%
|
(52)
-4%
|
(53)
-1%
|
(53)
0%
|
(56)
-7%
|
(61)
-7%
|
(67)
-10%
|
(76)
-14%
|
(76)
+0%
|
(81)
-7%
|
116
N/A
|
124
+7%
|
129
+4%
|
124
-3%
|
(68)
N/A
|
(69)
0%
|
(69)
0%
|
(54)
+21%
|
(52)
+5%
|
(49)
+4%
|
(49)
+1%
|
(52)
-8%
|
|
Net Income | |||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(18)
|
(22)
|
(53)
|
(58)
|
(61)
|
(65)
|
(44)
|
(47)
|
(50)
|
(52)
|
(53)
|
(53)
|
(56)
|
(61)
|
(67)
|
(76)
|
(76)
|
(81)
|
115
|
122
|
127
|
123
|
(69)
|
(68)
|
(69)
|
(54)
|
(52)
|
(49)
|
(49)
|
(52)
|
|
Net Income (Common) |
(18)
N/A
|
(22)
-23%
|
(53)
-137%
|
(58)
-9%
|
(61)
-6%
|
(65)
-6%
|
(44)
+32%
|
(47)
-6%
|
(50)
-8%
|
(52)
-4%
|
(53)
-1%
|
(53)
0%
|
(56)
-7%
|
(61)
-7%
|
(67)
-10%
|
(76)
-14%
|
(76)
+0%
|
(81)
-7%
|
110
N/A
|
118
+7%
|
123
+4%
|
120
-3%
|
(68)
N/A
|
(67)
+0%
|
(68)
-1%
|
(54)
+20%
|
(52)
+5%
|
(49)
+4%
|
(49)
+1%
|
(52)
-8%
|
|
EPS (Diluted) |
-0.74
N/A
|
-0.91
-23%
|
-2.16
-137%
|
-16.51
-664%
|
-2.49
+85%
|
-3.35
-35%
|
-1.78
+47%
|
-1.88
-6%
|
-2.03
-8%
|
-2.11
-4%
|
-1.73
+18%
|
-1.36
+21%
|
-1.46
-7%
|
-1.54
-5%
|
-1.21
+21%
|
-1.37
-13%
|
-1.27
+7%
|
-1.39
-9%
|
1.62
N/A
|
1.71
+6%
|
1.81
+6%
|
1.76
-3%
|
-0.96
N/A
|
-0.95
+1%
|
-0.98
-3%
|
-0.77
+21%
|
-0.73
+5%
|
-0.7
+4%
|
-0.69
+1%
|
-0.74
-7%
|